Literature DB >> 2831662

DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein.

V Bubb1, D J McCance, R Schlegel.   

Abstract

Infection of cervical epithelium by human papillomavirus type 16 (HPV-16) appears to be closely associated with the development of cervical dysplasia and carcinoma. By inference from genetic and biochemical studies of the bovine papillomavirus, the E5 ORF of the human papillomaviruses is anticipated to encode a "transforming" protein. In an effort to compare the E5 ORF of HPV-16 with other human papillomaviruses and bovine papillomavirus, we sequenced this region from a new isolate of HPV-16 which was derived from extrachromosomal viral DNA within a premalignant cervical lesion (cervical intraepithelial neoplasia, grade III, or CIN III). In addition, we also sequenced the original isolate of HPV-16 (derived from integrated viral DNA by Durst et al. [Proc. Natl. Acad. Sci. USA 80, 3812-3815 (1983)] and sequenced by Seedorf et al. [Virology 145, 181-185 (1985)]. Both HPV-16 isolates contained an additional nucleotide (T) at bp 3906. This nucleotide addition caused a frameshift in the E5 ORF such that it now contains an initiation codon at bp 3849; the frameshift also alters the predicted E5 NH2 terminus but retains the original COOH half of the protein. E5 proteins encoded by several HPVs which infect the genital region (e.g., types 6, 11, 16, 18, 33) exhibit a conserved trimodal hydrophobic structure, but not a conserved amino acid sequence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831662     DOI: 10.1016/0042-6822(88)90259-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Biologic properties and nucleotide sequence analysis of human papillomavirus type 51.

Authors:  O Lungu; C P Crum; S Silverstein
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens.

Authors:  P L Hermonat; L Han; P J Wendel; J G Quirk; S Stern; C L Lowery; T M Rechtin
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.

Authors:  C M Wheeler; T Yamada; A Hildesheim; S A Jenison
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes.

Authors:  S W Straight; B Herman; D J McCance
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.

Authors:  Benyue Zhang; Dan F Spandau; Ann Roman
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Mutational analysis of bovine papillomavirus type 1 E5 peptide domains involved in induction of cellular DNA synthesis.

Authors:  J A Rawls; P M Loewenstein; M Green
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Mutational analysis of human papillomavirus type 11 E5a oncoprotein.

Authors:  S L Chen; T Z Tsai; C P Han; Y P Tsao
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.

Authors:  S W Straight; P M Hinkle; R J Jewers; D J McCance
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.

Authors:  Yi-Fang Chen; Chih-Wei Lin; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16.

Authors:  C Leptak; S Ramon y Cajal; R Kulke; B H Horwitz; D J Riese; G P Dotto; D DiMaio
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.